Image

    Evaluation of the Use of Cyclophosphamide in Children Diagnosed with Steroid-Resistant Nephrotic Syndrome Treated at Fatmawati Hospital

    December 2022 in “ Jurnal Farmasi Klinik Base Practice ”
    Satriani Sinukaban, Bobby Setiadi Darmawan
    Studysummary In this study of children with nephrotic syndrome treated with cyclophosphamide, 59.4% achieved remission, and 40.6% experienced side effects including nausea, vomiting, and hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on rsupfatmawati.co.id →
    Discuss this study in the Community →

    Related research 1

    1. Olanzapine Induced Hair Loss: A Case Report Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · 2012